ANTIMICROBIAL RESISTANCE (AMR) SURVEILLANCE
Current AMR surveillance programs sponsored by the US-FDA and CDC use BIOMIC V3 systems to digitally read, interpret, and record standard AMR tests.
AMR Testing Modules with BIOMIC V3:
AMR Testing Modules with BIOMIC V3:
AMR Advantages with BIOMIC V3:
|
|
AMR Current Programs with BIOMIC V3:
- CDC: Carbapenem Resistance (CRE)** Learn More >
- CDC: Gonococcal Isolate Surveillance Program Learn More >
- US-FDA: Vet-LIRN Veterinary Laboratory Investigation and Response Network Learn More >
- US-FDA: NARMS National Antimicrobial Resistance Monitoring System Learn More >
- USDA: NAHLN National Animal Health Laboratory Network Learn More >
AMR Previous Program with BIOMIC V3:
From 1997-2010, 151 hospital labs in 40 countries with BIOMIC V3 systems participated in the ARTEMIS drug resistance study sponsored by Pfizer Pharmaceuticals. 50+ journal publications demonstrate BIOMIC V3's testing and AMR surveillance capabilities. View publications >
From 1997-2010, 151 hospital labs in 40 countries with BIOMIC V3 systems participated in the ARTEMIS drug resistance study sponsored by Pfizer Pharmaceuticals. 50+ journal publications demonstrate BIOMIC V3's testing and AMR surveillance capabilities. View publications >
AMR Multi-Lab Networks with BIOMIC V3:
Multiple BIOMIC V3 systems can be connected on a global network for hospital or private lab groups, government MOH programs, or multiple lab studies. Sites may collect test and QC results to monitor AMR trends from a central location. Study results may be used for regulatory filing, research, or marketing purposes.
Multiple BIOMIC V3 systems can be connected on a global network for hospital or private lab groups, government MOH programs, or multiple lab studies. Sites may collect test and QC results to monitor AMR trends from a central location. Study results may be used for regulatory filing, research, or marketing purposes.
